增加REG3A的表达促进了三阴性乳腺癌细胞中的瘤发生行为
Xiaoxia Jin1, Shuyun Yang1, Xiaoyun Lu1
1Department of Pathology, Affiliated Tumor Hospital of Nantong University, No.30 North Tongyang Road, Pingchao, Nantong, 226361, Jiangsu, China.
Breast cancer research : BCR
|June 5, 2024
概括
再生小岛衍生蛋白3A (REG3A) 通过激活Akt-mTOR通路来驱动三阴性乳腺癌 (TNBC) 的生长. 针对ZNF680规范的REG3A,为TNBC提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 三阴性乳腺癌 (TNBC) 需要新的治疗点.
- 再生岛屿衍生蛋白3A (REG3A),一种依赖的乳清素,正在研究其在乳腺癌中的作用.
研究的目的:
- 阐明REG3A在乳腺癌,特别是TNBC中的表达和功能意义.
- 确定REG3A在TNBC进展中的作用背后的分子机制.
- 探索ZNF680作为REG3A的潜在调节者.
主要方法:
- 对TCGA数据库和局部组织样本的生物信息学分析.
- 在体外研究中,使用对TNBC细胞中REG3A和ZNF680的基因操纵 (shRNA,CRISPR-sgRNA).
- 在体内皮下异种移植模型以评估瘤生长.
- 西部涂抹以评估蛋白质表达和通路激活 (Akt-mTOR).
主要成果:
- 在人类乳腺癌组织中,特别是TNBC中,REG3A的表达升高.
- REG3A促进TNBC细胞的增殖,迁移和入侵,同时抑制细胞亡.
- REG3A激活了Akt-mTOR信号通路,这对于其致癌功能至关重要.
- ZNF680作为REG3A的转录因子,增强其表达并促进瘤发生.
- 在体内抑制REG3A显著降低了TNBC异种移植的生长.
结论:
- 由ZNF680诱导的REG3A过度表达通过Akt-mTOR激活驱动TNBC瘤发生.
- REG3A代表了对三阴性乳腺癌的有前途和新的治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K


